Osborne Clarke advises iOnctura on €15M Series A financing
Osborne Clarke in Amsterdam has advised iOnctura, a clinical stage biopharmaceutical company, developing a pipeline of next generation molecules targeting...
Published on
28/01/2020
Read time
1m